GRISEOFULVIN Side Effects

6725639-X | Cardiovascular Disorder, Cold Sweat, Dizziness, Hepatomegaly, Immunoglobulins Increased, Listless, Lymphadenopathy, Shigella Infection, Splenomegaly
on May 13, 2010 Female patient from UNITED KINGDOM , 22 years of age, was diagnosed with trichophytosis and was treated with Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular disorder, cold sweat, dizziness (What is dizziness?), hepatomegaly, immunoglobulins increased, listless, lymphadenopathy, shigella infection, splenomegaly. Griseofulvin dosage: . Patient was hospitalized.

6282442-5 | Cutaneous Lupus Erythematosus, Dizziness, Headache, Malaise, Nausea
Patient was taking Griseofulvin (View Usage). Patient had the following side effects: cutaneous lupus erythematosus, dizziness (What is dizziness?), headache (What is headache?), malaise, nausea (What is nausea?) on Jun 09, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, was diagnosed with trichophytosis and. Griseofulvin dosage: .

6277991-X | Systemic Lupus Erythematosus
Adverse event was reported on Jul 14, 2009 by a Male patient taking Griseofulvin (View Usage) (Dosage: ) was diagnosed with trichophytosis and. Location: JAPAN , 64 years of age, After Griseofulvin was administered, patient had the following side effects: systemic lupus erythematosus. Patient was hospitalized.

6244976-9 | Disseminated Intravascular Coagulation, Encephalitis, Mixed Connective Tissue Disease
on Jun 11, 2009 Female patient from JAPAN , 36 years of age, was diagnosed with trichophytosis and was treated with Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, encephalitis (What is encephalitis?), mixed connective tissue disease. Griseofulvin dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).


6238162-6 | Cutaneous Lupus Erythematosus
on Jun 17, 2009 Female patient from JAPAN , 35 years of age, was diagnosed with onychomycosis, dermatomyositis and was treated with Griseofulvin (View Usage). Patient had the following side effects: cutaneous lupus erythematosus. Griseofulvin dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6238161-4 | Cutaneous Lupus Erythematosus
Patient was taking Griseofulvin (View Usage). After Griseofulvin was administered, patient had the following side effects: cutaneous lupus erythematosus on Jun 17, 2009 from JAPAN Additional patient health information: Female patient , 35 years of age, . Griseofulvin dosage: .

6236577-3 | Cardiovascular Disorder, Cold Sweat, Dizziness, Hepatomegaly, Listless, Lymphadenopathy, Splenomegaly, Systemic Lupus Erythematosus
Adverse event was reported on Jun 09, 2009 by a Female patient taking Griseofulvin (View Usage) (Dosage: ) was diagnosed with trichophytosis and. Location: UNITED KINGDOM , 22 years of age, Patient experienced the following unwanted or unexpected effects: cardiovascular disorder, cold sweat, dizziness (What is dizziness?), hepatomegaly, listless, lymphadenopathy, splenomegaly, systemic lupus erythematosus. Patient was hospitalized.

6230830-5 | Cutaneous Lupus Erythematosus
on Jun 15, 2009 Female patient from JAPAN , 35 years of age, was diagnosed with onychomycosis, dermatomyositis and was treated with Griseofulvin (View Usage). Patient had the following side effects: cutaneous lupus erythematosus. Griseofulvin dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6227327-5 | Cardiovascular Disorder, Cold Sweat, Diarrhoea, Dizziness, Fatigue, Headache, Hepatomegaly, Leukopenia, Listless
on Jun 09, 2009 Female patient from UNITED KINGDOM , 22 years of age, was diagnosed with trichophytosis and was treated with Griseofulvin (View Usage). After Griseofulvin was administered, patient had the following side effects: cardiovascular disorder, cold sweat, diarrhoea, dizziness (What is dizziness?), fatigue, headache (What is headache?), hepatomegaly, leukopenia, listless. Griseofulvin dosage: . Patient was hospitalized.

6227326-3 | Cutaneous Lupus Erythematosus, Dizziness, Headache, Malaise, Nausea
Patient was taking Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: cutaneous lupus erythematosus, dizziness (What is dizziness?), headache (What is headache?), malaise, nausea (What is nausea?) on Jun 09, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 64 years of age, was diagnosed with trichophytosis and. Griseofulvin dosage: .

6226366-8 | Asthenia, Gangrene, Glomerulonephritis Proliferative, Myositis, Renal Failure, Systemic Lupus Erythematosus, Vasculitis
Adverse event was reported on Mar 09, 2009 by a Female patient taking Griseofulvin (View Usage) (Dosage: Total Dose Could Not Have Exceeded 1 Mg) was diagnosed with respiratory tract infection, prophylaxis and. Location: UNITED KINGDOM , 22 years of age, Patient had the following side effects: asthenia, gangrene, glomerulonephritis proliferative, myositis (What is myositis?), renal failure, systemic lupus erythematosus, vasculitis (What is vasculitis?). During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6226365-6 | Systemic Lupus Erythematosus
on Mar 20, 2009 Female patient from UNITED STATES , 33 years of age, was diagnosed with trichophytosis and was treated with Griseofulvin (View Usage). After Griseofulvin was administered, patient had the following side effects: systemic lupus erythematosus. Griseofulvin dosage: . Patient was hospitalized.

6226364-4 | Alanine Aminotransferase Increased, Anaemia, Antinuclear Antibody Positive, Arthralgia, Aspartate Aminotransferase Increased, Complement Factor C3 Decreased, Complement Factor C4 Decreased, Cutaneous Lupus Erythematosus, Face Oedema
on Mar 09, 2009 Male patient from UNITED STATES , 16 years of age, was diagnosed with tinea capitis and was treated with Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, antinuclear antibody positive, arthralgia, aspartate aminotransferase increased, complement factor c3 decreased, complement factor c4 decreased, cutaneous lupus erythematosus, face oedema. Griseofulvin dosage: . Patient was hospitalized.

6226363-2 | Cutaneous Lupus Erythematosus
Patient was taking Griseofulvin (View Usage). Patient had the following side effects: cutaneous lupus erythematosus on Mar 09, 2009 from JAPAN Additional patient health information: Female patient , 35 years of age, . Griseofulvin dosage: .

6218511-5 | Abdominal Discomfort, Fatigue, Head Injury, Headache, Oropharyngeal Pain, Syncope, Thirst, Vomiting
Adverse event was reported on Jun 04, 2009 by a Male patient taking Griseofulvin (View Usage) (Dosage: 2 Teaspoons Bid Po) was diagnosed with tinea infection (What is tinea infection?) and. Location: UNITED STATES , child 7 years of age, weighting 59.20 lb, After Griseofulvin was administered, patient had the following side effects: abdominal discomfort, fatigue, head injury, headache (What is headache?), oropharyngeal pain, syncope, thirst, vomiting. During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ).

5954814-7 | Stevens-johnson Syndrome
on Nov 04, 2008 Male patient from MOROCCO , child 4 years of age, was diagnosed with tinea capitis and was treated with Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Griseofulvin dosage: 20 Mg/kg/d.

5849868-2 | Dizziness, Pyrexia
on Aug 18, 2008 Female patient from UNITED STATES , 39 years of age, weighting 140.0 lb, was diagnosed with tinea infection (What is tinea infection?) and was treated with Griseofulvin (View Usage). Patient had the following side effects: dizziness (What is dizziness?), pyrexia. Griseofulvin dosage: 1 Tablet Daily Po, 1 Week -approx-.

5794781-2 | Cheilitis, Conjunctivitis, Dermatitis Bullous, Epidermal Necrosis, Genital Erosion, Oral Mucosa Erosion, Perivascular Dermatitis, Purpura, Pyrexia
Patient was taking Griseofulvin (View Usage). After Griseofulvin was administered, patient had the following side effects: cheilitis, conjunctivitis, dermatitis bullous, epidermal necrosis, genital erosion, oral mucosa erosion, perivascular dermatitis, purpura, pyrexia on Jun 19, 2008 from MOROCCO Additional patient health information: Male patient , child 4 years of age, was diagnosed with tinea capitis and. Griseofulvin dosage: Qd.

5680043-0 | Confusional State, Diarrhoea, Dizziness, Fall, Pallor, Pyrexia, Unresponsive To Stimuli, Vomiting
Adverse event was reported on Mar 25, 2008 by a Male patient taking Griseofulvin (View Usage) (Dosage: 2 Teasponful In Morning For 6 Weeks Po) was diagnosed with tinea infection (What is tinea infection?) and. Location: UNITED STATES , child 4 years of age, weighting 39.00 lb, Patient experienced the following unwanted or unexpected effects: confusional state, diarrhoea, dizziness (What is dizziness?), fall (What is fall?), pallor, pyrexia, unresponsive to stimuli, vomiting.

5496503-1 | Oral Mucosal Blistering
on Oct 15, 2007 Male patient from UNITED STATES , child 3 years of age, weighting 35.01 lb, was diagnosed with tinea infection (What is tinea infection?) and was treated with Griseofulvin (View Usage). Patient had the following side effects: oral mucosal blistering. Griseofulvin dosage: .

5452678-1 | Stevens-johnson Syndrome
on Sep 03, 2007 Male patient from TUNISIA , 37 years of age, was treated with Griseofulvin (View Usage). After Griseofulvin was administered, patient had the following side effects: stevens-johnson syndrome. Griseofulvin dosage: .

5061684-0 | Photosensitivity Reaction
Patient was taking Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: photosensitivity reaction on May 26, 2006 from UNITED STATES Additional patient health information: Female patient , 21 years of age, weighting 108.5 lb, was diagnosed with nail tinea and. Griseofulvin dosage: . During the same period patient was treated with LAMISIL (250 Mg, Qd) (View Lamisil Review and Lamisil Label ).

4899071-8 | Dermatitis Exfoliative, Ichthyosis
Adverse event was reported on Jan 17, 2006 by a Male patient taking Griseofulvin (View Usage) (Dosage: 20 Mg/kg Daily, Oral) was diagnosed with tinea capitis and. Location: MOROCCO , 63 years of age, Patient had the following side effects: dermatitis exfoliative, ichthyosis. During the same period patient was treated with PENICILLIN (View Penicillin Review and Penicillin Label ), METICILLIN (METICILLIN) (View Meticillin (meticillin) Review and Meticillin (meticillin) Label ). Patient was hospitalized.

4852824-4 | Headache
on Dec 12, 2005 Male patient from UNITED STATES , weighting 209.4 lb, was treated with Griseofulvin (View Usage). After Griseofulvin was administered, patient had the following side effects: headache (What is headache?). Griseofulvin dosage: 500mg Twice A Day Po.

4849402-X | Ecchymosis, Haemoglobin Decreased, Haemorrhage, Muscle Swelling, Platelet Count Decreased, White Blood Cell Count Increased
on Nov 28, 2005 Male patient from UNITED STATES , 51 years of age, was diagnosed with dermatitis and was treated with Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis, haemoglobin decreased, haemorrhage, muscle swelling, platelet count decreased, white blood cell count increased. Griseofulvin dosage: 330 Mg Qd Oral. Patient was hospitalized.

4839982-2 | Erythema Multiforme, Hypersensitivity
Patient was taking Griseofulvin (View Usage). Patient had the following side effects: erythema multiforme, hypersensitivity on Nov 17, 2005 from INDIA Additional patient health information: Female patient , 40 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Griseofulvin dosage: 500 Mg Qd. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

4833283-4 | Arthritis, Gait Disturbance, Joint Swelling, Oedema Peripheral, Pain In Extremity, Pyrexia, Rash Maculo-papular
Adverse event was reported on Nov 11, 2005 by a Male patient taking Griseofulvin (View Usage) (Dosage: 200 Mg Qd Oral) was diagnosed with tinea capitis and. Location: ISRAEL , child 5 years of age, weighting 41.89 lb, After Griseofulvin was administered, patient had the following side effects: arthritis (What is arthritis?), gait disturbance, joint swelling, oedema peripheral, pain in extremity, pyrexia, rash maculo-papular.

4761205-3 | Blood Pressure Orthostatic Abnormal, Chest Discomfort, Chest Pain, Dehydration, Dizziness, Dyspnoea, Hyperhidrosis, Paraesthesia, Pulse Abnormal
on Sep 01, 2005 Male patient from UNITED STATES , 19 years of age, weighting 139.0 lb, was treated with Griseofulvin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure orthostatic abnormal, chest discomfort, chest pain (What is chest pain?), dehydration, dizziness (What is dizziness?), dyspnoea, hyperhidrosis, paraesthesia, pulse abnormal. Griseofulvin dosage: 250 Mg X 1 Oral.